Stephan Grupp
Sickle cell gene therapy and CAR T cell expert. Director of Cancer Immunotherapy and Cell Therapy/Transplant Section at CHOP and Professor of Peds @ U Penn
Stephan Grupp is the Chief of the Cell Therapy and Transplant Section and heads the Cancer Immunotherapy Frontier Program at Children's Hospital of Philadelphia, focusing on CAR T cell studies and global ALL cell therapy registration trials.
He earned his Bachelor's Degree in Biology, Doctor of Medicine (M.D.) in Medicine, and Doctor of Philosophy (Ph.D.) in Immunology from the University of Cincinnati College of Medicine.
Stephan Grupp is the former Director of Cancer Immunotherapy Frontier Program at Children's Hospital of Philadelphia, former Professor at Perelman School of Medicine at the University of Pennsylvania, and has held various roles at prestigious institutions like Harvard Medical School, Dana-Farber Cancer Institute, and Boston Children's Hospital.
People also Viewed
Mutual Connections
People also Viewed